Corindus Vascular Robotics (CVRS) Tops Q2 EPS by 1c

Corindus Vascular Robotics (NYSE: CVRS) reported Q2 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.3 million versus the consensus estimate of $2.9 million.

GUIDANCE:

Corindus Vascular Robotics sees FY2017 revenue of $13-15 million.

For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery